The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Leqvio… read more.
Bavarian Nordic A/S announced that Health Canada has approved Vimkunya (recombinant, adsorbed) for immunization to prevent disease caused by chikungunya virus infection for individuals 12 years of age… read more.
Breast milk helps shape the gut microbiota for longer than previously thought. Researchers from DTU and Rigshospitalet have discovered that sugars in breast milk, which are nondigestible by… read more.
Shionogi announced that it has received supplemental approval in Japan for the pediatric dosage and administration of XOCOVA (generic name: ensitrelvir fumaric acid; hereinafter “XOCOVA”), an anti-SARS-CoV-2 drug,… read more.
AbbVie announced that the EC has approved SKYRIZI (risankizumab) for the treatment of children and adolescents six years of age and older with moderate to severe plaque psoriasis… read more.
There has been a lot of discussion about how the age at menopause can affect menopause symptoms. A new study compared the prevalence and severity of menopause symptoms… read more.
Older adults discharged from hospital with a new prescription for a sedative, especially a benzodiazepine or antipsychotic, are at increased risk of falls and other negative consequences, according… read more.
A novel economic model projects that patients with heart failure would live longer lives and spend less time in hospital by expanding heart failure care to include pharmacist-… read more.
Pre-retrieval imaging is moving liver transplantation toward a more precise and less invasive era. A new evidence synthesis shows how ultrasound, computed tomography, and magnetic resonance imaging can… read more.
This study is the first to analyse obesity trends from 2019 to 2025, using NHS England electronic health records covering nearly 55 million adults. The scale and detail… read more.
Gilead Sciences announced that the EC has granted marketing authorization for Trodelvy (sacituzumab govitecan-hziy) as monotherapy for the treatment of adult patients with unresectable or metastatic triple-negative breast… read more.
An international survey has highlighted major gaps in cardio-oncology training, despite its increasing clinical importance.1 These results were presented at ESC Cardio-Oncology 2026, the second annual conference of the European Society… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
